Skip to main content
Journal cover image

Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer.

Publication ,  Journal Article
Morishita, R; Gibbons, GH; Horiuchi, M; Nakajima, M; Ellison, KE; Lee, W; Kaneda, Y; Ogihara, T; Dzau, VJ
Published in: J Cardiovasc Pharmacol Ther
July 1997

BACKGROUND: The effectiveness of antisense oligodeoxynucleotides for in vitro and in vivo studies is limited by a low efficiency of cellular uptake and instability due to degradation by nucleases. To overcome some of these problems, we recently developed a transfer method that utilizes inactivated Sendai virus (hemagglutinating virus of Japan [HVJ]) complexed with liposomes to deliver antisense oligodeoxynucleotides. In this study, we compared the effectiveness of the HVJ-liposome method versus a cationic liposome method versus passive uptake to deliver antisense oligodeoxynucleotides against basic fibroblast growth factor on angiotensin (Ang) II-induced rat vascular smooth muscle cell growth. METHODS AND RESULTS: Twenty to twenty-eight hours after transfection, antisense fibroblast growth factor oligodeoxynucleotides introduced by passive uptake and HVJ-liposome method decreased basal DNA synthesis significantly as compared to the sense, control, and scrambled oligodeoxynucleotides groups; however, 60-68 hours after transfection, only antisense fibroblast growth factor oligodeoxynucleotides transduced by the HVJ-liposome method resulted in a significant inhibition of DNA synthesis under basal and Ang II-(10(-;6)M) stimulated conditions. The IC(25) of oligodeoxynucleotides assessed by the inhibition of thymidine incorporation was significantly lower using the HVJ-liposome method than those using the other transfer methods. To clarify the mechanisms of cellular uptake of oligodeoxynucleotides with the HVJ-liposome method, we studied the cellular fate of fluorescein isothiocyanate (FITC)-labeled oligodeoxynucleotides FITC-oligodeoxynucleotides was localized in nuclei at 5 minutes after transfection with the HVJ-liposome method. In contrast, FITC-oligodeoxynucleotides introduced by passive uptake was detected in nonnuclear cellular compartments, possibly endosomes, but not the nuclei. Cellular fluorescence of oligodeoxynucleotides introduced by passive uptake disappeared within 24 hours, while that introduced by the HVJ-liposome method could be observed up to 72 hours. CONCLUSION: These results demonstrate that the HVJ-liposome transfer enhanced the effectiveness of AS-fibroblast growth factor via its specific molecular mechanisms of transfer.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Cardiovasc Pharmacol Ther

DOI

EISSN

1940-4034

Publication Date

July 1997

Volume

2

Issue

3

Start / End Page

213 / 222

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Morishita, R., Gibbons, G. H., Horiuchi, M., Nakajima, M., Ellison, K. E., Lee, W., … Dzau, V. J. (1997). Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer. J Cardiovasc Pharmacol Ther, 2(3), 213–222. https://doi.org/10.1177/107424849700200308
Morishita, R., G. H. Gibbons, M. Horiuchi, M. Nakajima, K. E. Ellison, W. Lee, Y. Kaneda, T. Ogihara, and V. J. Dzau. “Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer.J Cardiovasc Pharmacol Ther 2, no. 3 (July 1997): 213–22. https://doi.org/10.1177/107424849700200308.
Morishita R, Gibbons GH, Horiuchi M, Nakajima M, Ellison KE, Lee W, et al. Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer. J Cardiovasc Pharmacol Ther. 1997 Jul;2(3):213–22.
Morishita, R., et al. “Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer.J Cardiovasc Pharmacol Ther, vol. 2, no. 3, July 1997, pp. 213–22. Pubmed, doi:10.1177/107424849700200308.
Morishita R, Gibbons GH, Horiuchi M, Nakajima M, Ellison KE, Lee W, Kaneda Y, Ogihara T, Dzau VJ. Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer. J Cardiovasc Pharmacol Ther. 1997 Jul;2(3):213–222.
Journal cover image

Published In

J Cardiovasc Pharmacol Ther

DOI

EISSN

1940-4034

Publication Date

July 1997

Volume

2

Issue

3

Start / End Page

213 / 222

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology